Clinical Trial Update: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating norursodeoxycholic acid for primary sclerosing cholangitis has completed. The trial was sponsored by Dr. Falk Pharma GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• norUrsodeoxycholic Acid (norursodeoxycholic acid)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED